Abstract

Here, we surveyed the usage of MoO3 nanostructure in role of a photosensitizer to eradicate glioma cells. This is the first endeavor upon survey of usage of nanostructured MoO3 to treat glioma in vitro. Here, we offer a simple way for preparation of bioactive MoO3 nanostructure via two different routes; wet chemical and microwave. The influence of diverse experimental factors like various alcoholic solvents and presence of capping agent was investigated on the final properties of synthesized products. Dimension and morphology of inorganic molybdenum trioxide nanostructures checked with TEM, HRTEM and also SEM images. Moreover, the cytotoxicity effect of optimized MoO3 nanoparticles was investigated on T98 and A172 cell lines. Both T98 and A172 cell lines indicated dose-dependent manner in the presence of increasing concentration of MoO3 nanostructures, but T98 cells were less sensitive to MoO3 in comparison with A172. Anti-glioma role of MoO3 nanostructures excited with the aid of UVC illumination studied in vitro as well. By studying the UV exposure lonely, it is evident that UV effects on cell viability about 50% in both cell lines after 24h. Interestingly, by combining nanostructured MoO3 with UVC illumination, decrement in the proliferation value could be remarkably occurred in comparison with controls. The outcomes denote that the photodynamic therapy with the help of nanostructured MoO3 may be beneficial to treat glioma.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.